NDC 62032-533

NU-DERM system NORMAL-oily SKIN TRANSFORMATION TRIAL

Hydroquinone, Homosalate, Octisalate, And Zinc Oxide

NU-DERM system NORMAL-oily SKIN TRANSFORMATION TRIAL is a Kit in the Human Prescription Drug category. It is labeled and distributed by Obagi Cosmeceutical Llc. The primary component is .

Product ID62032-533_f81be314-ed4a-4910-8044-2eac72c76368
NDC62032-533
Product TypeHuman Prescription Drug
Proprietary NameNU-DERM system NORMAL-oily SKIN TRANSFORMATION TRIAL
Generic NameHydroquinone, Homosalate, Octisalate, And Zinc Oxide
Dosage FormKit
Marketing Start Date2019-12-02
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameOBAGI COSMECEUTICAL LLC
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 62032-533-60

1 KIT in 1 KIT (62032-533-60) * 57 g in 1 BOTTLE, PLASTIC * 28 g in 1 BOTTLE, PLASTIC * 28 g in 1 BOTTLE, PLASTIC * 85 g in 1 TUBE * 59 mL in 1 BOTTLE, PLASTIC * 59 mL in 1 BOTTLE, PLASTIC
Marketing Start Date2019-12-02
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "NU-DERM system NORMAL-oily SKIN TRANSFORMATION TRIAL" or generic name "Hydroquinone, Homosalate, Octisalate, And Zinc Oxide"

NDCBrand NameGeneric Name
62032-515NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION TRIALNU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION TRIAL
62032-532NU-DERM system NORMAL-DRYHydroquinone, Homosalate, Octisalate, and Zinc Oxide
62032-531NU-DERM System NORMAL-OilyHYDROQUINONE, HOMOSALATE, OCTISALATE, and ZINC OXIDE
62032-533NU-DERM system NORMAL-oilyHydroquinone, Homosalate, Octisalate, and Zinc Oxide
62032-535OBAGI-C RX System NORMAL-DRYHYDROQUINONE, HOMOSALATE, OCTISALATE, AND ZINC OXIDE
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.